Literature DB >> 9220160

MRP 8/14 as marker for Plasmodium falciparum-induced malaria episodes in individuals in a holoendemic area.

G Bordmann1, G Burmeister, S Saladin, H Urassa, S Mwankyusye, N Weiss, M Tanner.   

Abstract

Presence of Plasmodium falciparum parasites in the peripheral blood of patients in a holoendemic area does not necessarily show that their illness is due to malaria. The aim of the present project was therefore to look for biological markers related to symptomatology or clinical events during a malaria episode. We focused our work on a complex of heterodimeric calcium-binding proteins secreted by stimulated neutrophils and monocytes, named MIF or myeloid-related proteins (MRP 8/14). In a longitudinal study including 51 adults from Ifakara, Tanzania (84.7% prevalence for P. falciparum in adults during the study), the level of MRP 8/14 in the serum was significantly related to the parasite load (Spearman correlation coefficient, 0.52; P < 0.0001). In the serum from children up to 6 years admitted at a health post the MRP 8/14 levels were closely related to parasitemia but also to fever episodes (Spearman correlation coefficients, 0.96 and 0.736; P < 0.0001 and P < 0.001, respectively). Although not specific to malaria, the measurement of MRP 8/14 could be an additional tool in assessing malaria-related morbidity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220160      PMCID: PMC170546          DOI: 10.1128/cdli.4.4.435-439.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  22 in total

1.  Asymptomatic malaria infections--do they matter?

Authors:  B M Greenwood
Journal:  Parasitol Today       Date:  1987-07

2.  Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection.

Authors:  M Goebeler; J Roth; F Burwinkel; E Vollmer; W Böcker; C Sorg
Journal:  Transplantation       Date:  1994-08-15       Impact factor: 4.939

3.  Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues.

Authors:  G Zwadlo; J Brüggen; G Gerhards; R Schlegel; C Sorg
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

Review 4.  The calcium binding proteins MRP8 and MRP14 in acute and chronic inflammation.

Authors:  C Sorg
Journal:  Behring Inst Mitt       Date:  1992-04

5.  Immunological markers of childhood fevers in an area of intense and perennial malaria transmission.

Authors:  N Hurt; M Thein; T Smith; G Bordmann; H Gallati; N Drees; M Tanner; N Weiss
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

6.  Serum protein concentrations in Plasmodium falciparum malaria.

Authors:  W Graninger; F Thalhammer; U Hollenstein; G M Zotter; P G Kremsner
Journal:  Acta Trop       Date:  1992-12       Impact factor: 3.112

7.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

8.  Development of immunity against Plasmodium falciparum malaria: clinical and parasitologic immunity cannot be separated.

Authors:  E Petersen; B Høgh; N T Marbiah; K David; A P Hanson
Journal:  J Infect Dis       Date:  1991-11       Impact factor: 5.226

9.  Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils.

Authors:  P G Sohnle; C Collins-Lech; J H Wiessner
Journal:  J Infect Dis       Date:  1991-01       Impact factor: 5.226

10.  Genetic regulation of fever in Plasmodium falciparum malaria in Gambian twin children.

Authors:  A P Jepson; W A Banya; F Sisay-Joof; M Hassan-King; S Bennett; H C Whittle
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

View more
  7 in total

1.  Human eosinophils express RAGE, produce RAGE ligands, exhibit PKC-delta phosphorylation and enhanced viability in response to the RAGE ligand, S100B.

Authors:  Colleen S Curran; Paul J Bertics
Journal:  Int Immunol       Date:  2011-10-24       Impact factor: 4.823

Review 2.  The role of calprotectin in pediatric disease.

Authors:  George Vaos; Ioannis D Kostakis; Nick Zavras; Athanasios Chatzemichael
Journal:  Biomed Res Int       Date:  2013-09-23       Impact factor: 3.411

3.  Up-regulated S100 calcium binding protein A8 in Plasmodium-infected patients correlates with CD4(+)CD25(+)Foxp3 regulatory T cell generation.

Authors:  Hyeong-Woo Lee; Tong-Soo Kim; Yoon-Joong Kang; Jung-Yeon Kim; Sangeun Lee; Won-Ja Lee; Youngjoo Sohn; Hyeong-Woo Lee
Journal:  Malar J       Date:  2015-10-05       Impact factor: 2.979

4.  Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content.

Authors:  Natalia Tiberti; Sharissa L Latham; Stephen Bush; Amy Cohen; Robert O Opoka; Chandy C John; Annette Juillard; Georges E Grau; Valéry Combes
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

5.  Impact of neutrophil-secreted myeloid related proteins 8 and 14 (MRP 8/14) on leishmaniasis progression.

Authors:  Irazú Contreras; Marina T Shio; Annabelle Cesaro; Philippe A Tessier; Martin Olivier
Journal:  PLoS Negl Trop Dis       Date:  2013-09-26

6.  Signatures of malaria-associated pathology revealed by high-resolution whole-blood transcriptomics in a rodent model of malaria.

Authors:  Jing-Wen Lin; Jan Sodenkamp; Deirdre Cunningham; Katrien Deroost; Tshibuayi Christine Tshitenge; Sarah McLaughlin; Tracey J Lamb; Bradley Spencer-Dene; Caroline Hosking; Jai Ramesar; Chris J Janse; Christine Graham; Anne O'Garra; Jean Langhorne
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

7.  Exacerbation of hepatic injury during rodent malaria by myeloid-related protein 14.

Authors:  Haruka Mizobuchi; Wataru Fujii; Shoko Isokawa; Kanna Ishizuka; Yihan Wang; Sayoko Watanabe; Chizu Sanjoba; Yoshitsugu Matsumoto; Yasuyuki Goto
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.